Symbols / CURX Stock $0.32 -3.73% Curanex Pharmaceuticals Inc

Healthcare • Biotechnology • United States • NCM
CURX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Jun Liu
Exch · Country NCM · United States
Market Cap 8.93M
Enterprise Value 19.13M
Income -435.03K
Sales —
FCF (ttm) -504.46K
Book/sh 0.01
Cash/sh 0.00
Employees —
Insider 10d —
IPO Aug 26, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B 24.25
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio 1.43
Current Ratio 9.37
Debt/Eq 155.99
LT Debt/Eq —
EPS (ttm) -0.02
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -30.03%
ROE -85.25%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 28.34M
Shs Float 8.91M
Insider Own 67.81%
Instit Own 0.00%
Short Float 0.67%
Short Ratio 0.03
Short Interest 137.29K
52W High 9.18
vs 52W High -96.57%
52W Low 0.26
vs 52W Low 20.31%
Beta —
Impl. Vol. —
Rel Volume 0.01
Avg Volume 4.37M
Volume 51.06K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.33
Price $0.32
Change -3.73%
About

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.32
Latest analyst target
3. DCF / Fair value
$-0.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.32
Low
—
High
—
Mean
—
News
RSS: Latest CURX news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
-100.00%
0.03
Operating Revenue
0.00
0.00
0.00
-100.00%
0.03
Cost Of Revenue
—
—
0.00
-100.00%
0.02
Reconciled Cost Of Revenue
—
—
0.00
-100.00%
0.02
Gross Profit
—
—
0.00
-100.00%
0.00
Operating Expense
4.24
+1359.81%
0.29
+1404.75%
0.02
-21.75%
0.02
Research And Development
2.99
0.00
—
—
Selling General And Administration
1.25
+331.56%
0.29
+1404.75%
0.02
-21.75%
0.02
General And Administrative Expense
1.25
+331.56%
0.29
+1404.75%
0.02
-21.75%
0.02
Other Gand A
1.25
+331.56%
0.29
+1404.75%
0.02
-21.75%
0.02
Total Expenses
4.24
+1359.81%
0.29
+1404.75%
0.02
-58.26%
0.05
Operating Income
-4.24
-1359.81%
-0.29
-1404.75%
-0.02
+4.62%
-0.02
Total Operating Income As Reported
-4.24
-1061.19%
-0.37
-1791.71%
-0.02
+4.62%
-0.02
EBITDA
-4.14
-1044.43%
-0.36
-1967.76%
-0.02
-1990.05%
0.00
Normalized EBITDA
-4.14
-1342.38%
-0.29
-1540.62%
-0.02
-1990.05%
0.00
Reconciled Depreciation
0.08
0.00
-100.00%
0.00
-91.42%
0.02
EBIT
-4.22
-1066.39%
-0.36
-1773.28%
-0.02
+4.62%
-0.02
Total Unusual Items
0.00
+100.00%
-0.07
0.00
—
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-0.07
0.00
—
Special Income Charges
0.00
+100.00%
-0.07
0.00
—
Impairment Of Capital Assets
0.00
-100.00%
0.07
0.00
—
Net Income
-4.23
-1068.75%
-0.36
-1783.04%
-0.02
+5.12%
-0.02
Pretax Income
-4.23
-1068.75%
-0.36
-1783.04%
-0.02
+5.12%
-0.02
Net Non Operating Interest Income Expense
-0.01
0.00
—
—
Interest Expense Non Operating
0.01
0.00
—
—
Net Interest Income
-0.01
0.00
—
—
Interest Expense
0.01
0.00
—
—
Other Income Expense
0.02
+131.65%
-0.07
-71220.00%
0.00
—
Other Non Operating Income Expenses
0.02
+532.93%
0.00
+3456.00%
0.00
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-4.23
-1068.75%
-0.36
-1783.04%
-0.02
+5.12%
-0.02
Net Income From Continuing Operation Net Minority Interest
-4.23
-1068.75%
-0.36
-1783.04%
-0.02
+5.12%
-0.02
Net Income From Continuing And Discontinued Operation
-4.23
-1068.75%
-0.36
-1783.04%
-0.02
+5.12%
-0.02
Net Income Continuous Operations
-4.23
-1068.75%
-0.36
-1783.04%
-0.02
+5.12%
-0.02
Normalized Income
-4.23
-1373.03%
-0.29
-1394.06%
-0.02
+5.12%
-0.02
Net Income Common Stockholders
-4.23
-1068.75%
-0.36
-1783.04%
-0.02
+5.12%
-0.02
Diluted EPS
—
-0.01
-1782.51%
-0.00
+96.54%
-0.02
Basic EPS
—
-0.01
-1782.51%
-0.00
+96.54%
-0.02
Basic Average Shares
—
27.75
-33.93%
42.00
+0.00%
42.00
Diluted Average Shares
—
42.00
+0.00%
42.00
+0.00%
42.00
Diluted NI Availto Com Stockholders
-4.23
-1068.75%
-0.36
-1783.04%
-0.02
+5.12%
-0.02
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
11.58
+2135.83%
0.52
+596.47%
0.07
+626.80%
0.01
Current Assets
11.23
+2067.74%
0.52
+596.47%
0.07
+626.80%
0.01
Cash Cash Equivalents And Short Term Investments
4.97
+3240.12%
0.15
+100.21%
0.07
+2960.33%
0.00
Cash And Cash Equivalents
4.97
+3240.12%
0.15
+100.21%
0.07
+2960.33%
0.00
Cash Financial
4.97
+3240.12%
0.15
+100.21%
0.07
+2960.33%
0.00
Receivables
—
—
0.00
-100.00%
0.00
Inventory
—
—
0.00
-100.00%
0.00
Prepaid Assets
6.25
+530381.26%
0.00
0.00
—
Current Deferred Assets
0.00
-100.00%
0.37
0.00
—
Other Current Assets
—
0.37
—
0.00
Total Non Current Assets
0.35
0.00
0.00
0.00
Net PPE
0.35
0.00
—
—
Gross PPE
0.35
0.00
—
—
Other Properties
0.35
—
—
—
Total Liabilities Net Minority Interest
0.36
+2377.12%
0.01
+2.09%
0.01
0.00
Current Liabilities
0.14
+840.17%
0.01
+2.09%
0.01
0.00
Payables And Accrued Expenses
0.01
-1.61%
0.01
+2.09%
0.01
0.00
Payables
0.00
-51.22%
0.01
+737.50%
0.00
—
Accounts Payable
0.00
-51.48%
0.01
0.00
—
Current Accrued Expenses
0.01
+24.50%
0.01
-30.17%
0.01
0.00
Total Tax Payable
0.00
+0.00%
0.00
-95.83%
0.00
0.00
Current Debt And Capital Lease Obligation
0.12
—
—
—
Current Capital Lease Obligation
0.12
0.00
—
—
Total Non Current Liabilities Net Minority Interest
0.22
0.00
0.00
0.00
Long Term Debt And Capital Lease Obligation
0.22
0.00
—
—
Long Term Capital Lease Obligation
0.22
0.00
—
—
Stockholders Equity
11.22
+2128.84%
0.50
+737.68%
0.06
+487.28%
0.01
Common Stock Equity
11.22
+2129.26%
0.50
+737.51%
0.06
+487.28%
0.01
Capital Stock
0.00
+17.36%
0.00
+4066.67%
0.00
-40.00%
0.00
Common Stock
0.00
+18.08%
0.00
+3900.00%
0.00
-40.00%
0.00
Preferred Stock
0.00
+0.00%
0.00
0.00
0.00
Share Issued
28.34
+2.13%
27.75
+0.00%
27.75
+0.00%
27.75
Ordinary Shares Number
28.34
+2.13%
27.75
+0.00%
27.75
+0.00%
27.75
Additional Paid In Capital
16.06
+1639.80%
0.92
+663.24%
0.12
+133.19%
0.05
Retained Earnings
-4.85
-678.79%
-0.62
-138.54%
-0.26
-7.94%
-0.24
Total Equity Gross Minority Interest
11.22
+2128.84%
0.50
+737.68%
0.06
+487.28%
0.01
Total Capitalization
11.22
+2128.84%
0.50
+737.68%
0.06
+487.28%
0.01
Working Capital
11.09
+2103.29%
0.50
+737.68%
0.06
+487.28%
0.01
Invested Capital
11.22
+2129.26%
0.50
+737.51%
0.06
+487.28%
0.01
Total Debt
0.35
0.00
—
—
Capital Lease Obligations
0.35
0.00
—
—
Net Tangible Assets
11.22
+2128.84%
0.50
+737.68%
0.06
+487.28%
0.01
Tangible Book Value
11.22
+2129.26%
0.50
+737.51%
0.06
+487.28%
0.01
Duefrom Related Parties Current
—
—
0.00
-100.00%
0.00
Other Equity Interest
—
0.20
+0.00%
0.20
+0.00%
0.20
Preferred Stock Equity
0.00
+0.00%
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-10.48
-1787.14%
-0.56
-462879.17%
-0.00
-103.60%
0.00
Cash Flow From Continuing Operating Activities
-10.48
-1787.14%
-0.56
-462879.17%
-0.00
-103.60%
0.00
Net Income From Continuing Operations
-4.23
-1068.75%
-0.36
-1783.04%
-0.02
+5.12%
-0.02
Depreciation Amortization Depletion
0.08
0.00
-100.00%
0.00
-91.42%
0.02
Depreciation
0.08
0.00
-100.00%
0.00
-91.42%
0.02
Depreciation And Amortization
0.08
0.00
-100.00%
0.00
-91.42%
0.02
Asset Impairment Charge
0.00
-100.00%
0.07
—
—
Change In Working Capital
-6.34
-2258.65%
-0.27
-1656.77%
0.02
+616.01%
0.00
Change In Inventory
—
0.00
-100.00%
0.00
-86.15%
0.02
Change In Prepaid Assets
-6.25
-530289.99%
-0.00
0.00
—
Change In Payables And Accrued Expense
-0.00
-178.26%
0.00
-97.91%
0.01
0.00
Change In Accrued Expense
0.00
+149.78%
-0.00
-132.93%
0.01
0.00
Change In Payable
-0.00
-151.48%
0.01
—
—
Change In Account Payable
-0.00
-151.48%
0.01
0.00
—
Change In Other Current Assets
0.00
+100.00%
-0.27
0.00
—
Change In Other Current Liabilities
-0.09
0.00
0.00
+100.00%
-0.02
Financing Cash Flow
15.31
+2329.57%
0.63
+774.46%
0.07
+2501.87%
-0.00
Cash Flow From Continuing Financing Activities
15.31
+2329.57%
0.63
+774.46%
0.07
+2501.87%
-0.00
Net Common Stock Issuance
15.66
+2384.95%
0.63
+812.30%
0.07
0.00
Net Other Financing Charges
-0.35
—
0.00
+200.00%
-0.00
Changes In Cash
4.82
+6373.32%
0.07
+3.60%
0.07
+21309.52%
0.00
Beginning Cash Position
0.15
+100.21%
0.07
+2960.33%
0.00
+16.05%
0.00
End Cash Position
4.97
+3240.12%
0.15
+100.21%
0.07
+2960.33%
0.00
Free Cash Flow
-10.48
-1787.14%
-0.56
-462879.17%
-0.00
-103.60%
0.00
Common Stock Issuance
15.66
+2384.95%
0.63
+812.30%
0.07
0.00
Issuance Of Capital Stock
15.66
+2384.56%
0.63
+812.45%
0.07
0.00
Net Preferred Stock Issuance
0.00
-100.00%
0.00
0.00
—
Preferred Stock Issuance
0.00
-100.00%
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category